These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14510953)

  • 1. Phenotype, function and chimaerism of monocyte-derived blood dendritic cells after allogeneic haematopoietic stem cell transplantation.
    Nachbaur D; Kircher B; Eisendle K; Lätzer K; Haun M; Gastl G
    Br J Haematol; 2003 Oct; 123(1):119-26. PubMed ID: 14510953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation.
    Mattsson J; Uzunel M; Brune M; Hentschke P; Barkholt L; Stierner U; Aschan J; Ringdén O
    Br J Haematol; 2001 Dec; 115(4):935-44. PubMed ID: 11843830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chimaerism analysis and kinetics on allogeneic haematopoietic stem cell transplantation outcome after conventional and reduced-intensity conditioning regimens.
    Michallet AS; Fürst S; Le QH; Dubois V; Praire A; Nicolini F; Thomas X; Rafii H; Gebuhrer L; Michallet M
    Br J Haematol; 2005 Mar; 128(5):676-89. PubMed ID: 15725090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of chimaerism in thalassaemic children undergoing stem cell transplantation.
    Amrolia PJ; Vulliamy T; Vassiliou G; Lawson S; Bryon J; Kaeda J; Dokal I; Johnston R; Veys P; Darbyshire P; Roberts IA
    Br J Haematol; 2001 Jul; 114(1):219-25. PubMed ID: 11472371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.
    Levenga H; Schaap N; Maas F; Esendam B; Fredrix H; Greupink-Draaisma A; de Witte T; Dolstra H; Raymakers R
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):320-32. PubMed ID: 19835972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
    Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
    Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
    Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
    Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
    Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning.
    Panse JP; Heimfeld S; Guthrie KA; Maris MB; Maloney DG; Baril BB; Little MT; Chauncey TR; Storer BE; Storb R; Sandmaier BM
    Br J Haematol; 2005 Mar; 128(5):659-67. PubMed ID: 15725088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells in allogeneic hematopoietic stem cell transplantation.
    Nachbaur D; Kircher B
    Leuk Lymphoma; 2005 Oct; 46(10):1387-96. PubMed ID: 16194884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.
    Martino R; Caballero MD; Canals C; Simón JA; Solano C; Urbano-Ispízua A; Bargay J; Rayón C; Léon A; Sarrá J; Odriozola J; Conde JG; Sierra J; San Miguel J; ;
    Br J Haematol; 2001 Dec; 115(3):653-9. PubMed ID: 11736950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.
    Matthews K; Lim Z; Pearce L; Pagliuca A; Alejandro Madrigal J; Mufti GJ; Barber LD
    Br J Haematol; 2010 Jun; 149(6):879-89. PubMed ID: 20346011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse.
    Bader P; Stoll K; Huber S; Geiselhart A; Handgretinger R; Niemeyer C; Einsele H; Schlegel PG; Niethammer D; Beck J; Klingebiel T
    Br J Haematol; 2000 Mar; 108(4):761-8. PubMed ID: 10792281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation.
    Wäsch R; Bertz H; Kunzmann R; Finke J
    Br J Haematol; 2000 Jun; 109(4):743-50. PubMed ID: 10929024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.
    Rubio MT; Savani BN; Labopin M; Piemontese S; Polge E; Ciceri F; Bacigalupo A; Arcese W; Koc Y; Beelen D; Gülbas Z; Wu D; Santarone S; Tischer J; Afanasyev B; Schmid C; Giebel S; Mohty M; Nagler A
    J Hematol Oncol; 2016 Mar; 9():25. PubMed ID: 26980295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes.
    Lim ZY; Pearce L; Ho AY; Barber L; Ingram W; Usai M; Tobal K; Devereux S; Pagliuca A; Mufti GJ
    Br J Haematol; 2007 Aug; 138(4):517-26. PubMed ID: 17608767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
    Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
    Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.
    Dominietto A; Raiola AM; van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Frassoni F; Casarino L; Verdiani S; Bacigalupo A
    Br J Haematol; 2001 Jan; 112(1):219-27. PubMed ID: 11167808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.